Trial Details
TERMINATEDBasic Information
| Clinical ID | c2196 |
|---|---|
| Identifier | NCT03850509 |
| Trial Title | Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: OPS-2071|DRUG: Placebo |
Participant Information
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-02-25 |
|---|---|
| Primary Completion Date | 2020-05-22 |
| Completion Date | 2020-05-22 |